 | • レポートコード：QYR2104Z1314 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、慢性特発性便秘症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リナクロチド、ルビプロストン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性特発性便秘症治療薬の市場動向 ・企業の競争状況、市場シェア ・慢性特発性便秘症治療薬の種類別市場規模（リナクロチド、ルビプロストン、その他） ・慢性特発性便秘症治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・慢性特発性便秘症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・慢性特発性便秘症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性特発性便秘症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性特発性便秘症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性特発性便秘症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Glaxosmithkline、Roche Holding AG、Sanofi、Bayer AG、Merck、Eli Lilly、Allergens、Chugai Pharmaceutical、Ferring International Center S.A、Synergy Pharmaceuticals、Salix Pharmaceuticals Ltd、Sucampo Pharmaceuticals Inc、Ironwood Pharmaceuticals Inc、Bausch Health、Daiichi Sankyo、Cosmo Pharmaceuticals SA、Progenics Pharmaceuticals Inc、Theravance Biopharma Inc） ・結論 |
Market Analysis and Insights: Global Chronic Idiopathic Constipation Drugs Market
The global Chronic Idiopathic Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Idiopathic Constipation Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Idiopathic Constipation Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Idiopathic Constipation Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Idiopathic Constipation Drugs market.
Global Chronic Idiopathic Constipation Drugs Scope and Market Size
Chronic Idiopathic Constipation Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Linaclotide
Lubiprostone
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Sanofi
Bayer AG
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Bausch Health
Daiichi Sankyo
Cosmo Pharmaceuticals SA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Linaclotide
1.2.3 Lubiprostone
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Constipation Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Idiopathic Constipation Drugs Market Perspective (2016-2027)
2.2 Chronic Idiopathic Constipation Drugs Growth Trends by Regions
2.2.1 Chronic Idiopathic Constipation Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Idiopathic Constipation Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Idiopathic Constipation Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Idiopathic Constipation Drugs Industry Dynamic
2.3.1 Chronic Idiopathic Constipation Drugs Market Trends
2.3.2 Chronic Idiopathic Constipation Drugs Market Drivers
2.3.3 Chronic Idiopathic Constipation Drugs Market Challenges
2.3.4 Chronic Idiopathic Constipation Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Constipation Drugs Players by Revenue
3.1.1 Global Top Chronic Idiopathic Constipation Drugs Players by Revenue (2016-2021)
3.1.2 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Idiopathic Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Idiopathic Constipation Drugs Revenue
3.4 Global Chronic Idiopathic Constipation Drugs Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Constipation Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Drugs Revenue in 2020
3.5 Chronic Idiopathic Constipation Drugs Key Players Head office and Area Served
3.6 Key Players Chronic Idiopathic Constipation Drugs Product Solution and Service
3.7 Date of Enter into Chronic Idiopathic Constipation Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Idiopathic Constipation Drugs Breakdown Data by Type
4.1 Global Chronic Idiopathic Constipation Drugs Historic Market Size by Type (2016-2021)
4.2 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Type (2022-2027)
5 Chronic Idiopathic Constipation Drugs Breakdown Data by Application
5.1 Global Chronic Idiopathic Constipation Drugs Historic Market Size by Application (2016-2021)
5.2 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chronic Idiopathic Constipation Drugs Market Size (2016-2027)
6.2 North America Chronic Idiopathic Constipation Drugs Market Size by Type
6.2.1 North America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021)
6.2.2 North America Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027)
6.2.3 North America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2027)
6.3 North America Chronic Idiopathic Constipation Drugs Market Size by Application
6.3.1 North America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021)
6.3.2 North America Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027)
6.3.3 North America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2027)
6.4 North America Chronic Idiopathic Constipation Drugs Market Size by Country
6.4.1 North America Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021)
6.4.2 North America Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chronic Idiopathic Constipation Drugs Market Size (2016-2027)
7.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Type
7.2.1 Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021)
7.2.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027)
7.2.3 Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2027)
7.3 Europe Chronic Idiopathic Constipation Drugs Market Size by Application
7.3.1 Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021)
7.3.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027)
7.3.3 Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2027)
7.4 Europe Chronic Idiopathic Constipation Drugs Market Size by Country
7.4.1 Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021)
7.4.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size (2016-2027)
8.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type
8.2.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application
8.3.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Region
8.4.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Idiopathic Constipation Drugs Market Size (2016-2027)
9.2 Latin America Chronic Idiopathic Constipation Drugs Market Size by Type
9.2.1 Latin America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2027)
9.3 Latin America Chronic Idiopathic Constipation Drugs Market Size by Application
9.3.1 Latin America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2027)
9.4 Latin America Chronic Idiopathic Constipation Drugs Market Size by Country
9.4.1 Latin America Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size (2016-2027)
10.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type
10.2.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application
10.3.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Country
10.4.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chronic Idiopathic Constipation Drugs Introduction
11.1.4 Pfizer Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Details
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Introduction
11.2.4 Glaxosmithkline Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.2.5 Glaxosmithkline Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Introduction
11.3.4 Roche Holding AG Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.3.5 Roche Holding AG Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Chronic Idiopathic Constipation Drugs Introduction
11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Chronic Idiopathic Constipation Drugs Introduction
11.5.4 Bayer AG Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Idiopathic Constipation Drugs Introduction
11.6.4 Merck Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Chronic Idiopathic Constipation Drugs Introduction
11.7.4 Eli Lilly Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.7.5 Eli Lilly Recent Development
11.8 Allergens
11.8.1 Allergens Company Details
11.8.2 Allergens Business Overview
11.8.3 Allergens Chronic Idiopathic Constipation Drugs Introduction
11.8.4 Allergens Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.8.5 Allergens Recent Development
11.9 Chugai Pharmaceutical
11.9.1 Chugai Pharmaceutical Company Details
11.9.2 Chugai Pharmaceutical Business Overview
11.9.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Introduction
11.9.4 Chugai Pharmaceutical Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.9.5 Chugai Pharmaceutical Recent Development
11.10 Ferring International Center S.A
11.10.1 Ferring International Center S.A Company Details
11.10.2 Ferring International Center S.A Business Overview
11.10.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Introduction
11.10.4 Ferring International Center S.A Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.10.5 Ferring International Center S.A Recent Development
11.11 Synergy Pharmaceuticals
11.11.1 Synergy Pharmaceuticals Company Details
11.11.2 Synergy Pharmaceuticals Business Overview
11.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Introduction
11.11.4 Synergy Pharmaceuticals Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.11.5 Synergy Pharmaceuticals Recent Development
11.12 Salix Pharmaceuticals Ltd
11.12.1 Salix Pharmaceuticals Ltd Company Details
11.12.2 Salix Pharmaceuticals Ltd Business Overview
11.12.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Introduction
11.12.4 Salix Pharmaceuticals Ltd Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.12.5 Salix Pharmaceuticals Ltd Recent Development
11.13 Sucampo Pharmaceuticals Inc
11.13.1 Sucampo Pharmaceuticals Inc Company Details
11.13.2 Sucampo Pharmaceuticals Inc Business Overview
11.13.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
11.13.4 Sucampo Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.13.5 Sucampo Pharmaceuticals Inc Recent Development
11.14 Ironwood Pharmaceuticals Inc
11.14.1 Ironwood Pharmaceuticals Inc Company Details
11.14.2 Ironwood Pharmaceuticals Inc Business Overview
11.14.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
11.14.4 Ironwood Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.14.5 Ironwood Pharmaceuticals Inc Recent Development
11.15 Bausch Health
11.15.1 Bausch Health Company Details
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Chronic Idiopathic Constipation Drugs Introduction
11.15.4 Bausch Health Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.15.5 Bausch Health Recent Development
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Details
11.16.2 Daiichi Sankyo Business Overview
11.16.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Introduction
11.16.4 Daiichi Sankyo Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.16.5 Daiichi Sankyo Recent Development
11.17 Cosmo Pharmaceuticals SA
11.17.1 Cosmo Pharmaceuticals SA Company Details
11.17.2 Cosmo Pharmaceuticals SA Business Overview
11.17.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Introduction
11.17.4 Cosmo Pharmaceuticals SA Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.17.5 Cosmo Pharmaceuticals SA Recent Development
11.18 Progenics Pharmaceuticals Inc
11.18.1 Progenics Pharmaceuticals Inc Company Details
11.18.2 Progenics Pharmaceuticals Inc Business Overview
11.18.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
11.18.4 Progenics Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
11.18.5 Progenics Pharmaceuticals Inc Recent Development
11.18 Theravance Biopharma Inc
.1 Theravance Biopharma Inc Company Details
.2 Theravance Biopharma Inc Business Overview
.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Introduction
.4 Theravance Biopharma Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021)
.5 Theravance Biopharma Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Linaclotide
Table 3. Key Players of Lubiprostone
Table 4. Key Players of Other
Table 5. Global Chronic Idiopathic Constipation Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Idiopathic Constipation Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Idiopathic Constipation Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2016-2021)
Table 9. Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2022-2027)
Table 11. Chronic Idiopathic Constipation Drugs Market Trends
Table 12. Chronic Idiopathic Constipation Drugs Market Drivers
Table 13. Chronic Idiopathic Constipation Drugs Market Challenges
Table 14. Chronic Idiopathic Constipation Drugs Market Restraints
Table 15. Global Chronic Idiopathic Constipation Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Idiopathic Constipation Drugs Market Share by Players (2016-2021)
Table 17. Global Top Chronic Idiopathic Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Drugs as of 2020)
Table 18. Ranking of Global Top Chronic Idiopathic Constipation Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Idiopathic Constipation Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Idiopathic Constipation Drugs Product Solution and Service
Table 22. Date of Enter into Chronic Idiopathic Constipation Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Idiopathic Constipation Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Chronic Idiopathic Constipation Drugs Product
Table 65. Pfizer Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Glaxosmithkline Company Details
Table 68. Glaxosmithkline Business Overview
Table 69. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product
Table 70. Glaxosmithkline Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 71. Glaxosmithkline Recent Development
Table 72. Roche Holding AG Company Details
Table 73. Roche Holding AG Business Overview
Table 74. Roche Holding AG Chronic Idiopathic Constipation Drugs Product
Table 75. Roche Holding AG Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 76. Roche Holding AG Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Chronic Idiopathic Constipation Drugs Product
Table 80. Sanofi Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Bayer AG Company Details
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Chronic Idiopathic Constipation Drugs Product
Table 85. Bayer AG Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 86. Bayer AG Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Chronic Idiopathic Constipation Drugs Product
Table 90. Merck Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Chronic Idiopathic Constipation Drugs Product
Table 95. Eli Lilly Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 96. Eli Lilly Recent Development
Table 97. Allergens Company Details
Table 98. Allergens Business Overview
Table 99. Allergens Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 100. Allergens Recent Development
Table 101. Chugai Pharmaceutical Company Details
Table 102. Chugai Pharmaceutical Business Overview
Table 103. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product
Table 104. Chugai Pharmaceutical Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 105. Chugai Pharmaceutical Recent Development
Table 106. Ferring International Center S.A Company Details
Table 107. Ferring International Center S.A Business Overview
Table 108. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product
Table 109. Ferring International Center S.A Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 110. Ferring International Center S.A Recent Development
Table 111. Synergy Pharmaceuticals Company Details
Table 112. Synergy Pharmaceuticals Business Overview
Table 113. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product
Table 114. Synergy Pharmaceuticals Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 115. Synergy Pharmaceuticals Recent Development
Table 116. Salix Pharmaceuticals Ltd Company Details
Table 117. Salix Pharmaceuticals Ltd Business Overview
Table 118. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product
Table 119. Salix Pharmaceuticals Ltd Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 120. Salix Pharmaceuticals Ltd Recent Development
Table 121. Sucampo Pharmaceuticals Inc Company Details
Table 122. Sucampo Pharmaceuticals Inc Business Overview
Table 123. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product
Table 124. Sucampo Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 125. Sucampo Pharmaceuticals Inc Recent Development
Table 126. Ironwood Pharmaceuticals Inc Company Details
Table 127. Ironwood Pharmaceuticals Inc Business Overview
Table 128. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product
Table 129. Ironwood Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 130. Ironwood Pharmaceuticals Inc Recent Development
Table 131. Bausch Health Company Details
Table 132. Bausch Health Business Overview
Table 133. Bausch Health Chronic Idiopathic Constipation Drugs Product
Table 134. Bausch Health Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 135. Bausch Health Recent Development
Table 136. Daiichi Sankyo Company Details
Table 137. Daiichi Sankyo Business Overview
Table 138. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product
Table 139. Daiichi Sankyo Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 140. Daiichi Sankyo Recent Development
Table 141. Cosmo Pharmaceuticals SA Company Details
Table 142. Cosmo Pharmaceuticals SA Business Overview
Table 143. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product
Table 144. Cosmo Pharmaceuticals SA Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 145. Cosmo Pharmaceuticals SA Recent Development
Table 146. Progenics Pharmaceuticals Inc Company Details
Table 147. Progenics Pharmaceuticals Inc Business Overview
Table 148. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product
Table 149. Progenics Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 150. Progenics Pharmaceuticals Inc Recent Development
Table 151. Theravance Biopharma Inc Company Details
Table 152. Theravance Biopharma Inc Business Overview
Table 153. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product
Table 154. Theravance Biopharma Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2016-2021) & (US$ Million)
Table 155. Theravance Biopharma Inc Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Idiopathic Constipation Drugs Market Share by Type: 2020 VS 2027
Figure 2. Linaclotide Features
Figure 3. Lubiprostone Features
Figure 4. Other Features
Figure 5. Global Chronic Idiopathic Constipation Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Chronic Idiopathic Constipation Drugs Report Years Considered
Figure 10. Global Chronic Idiopathic Constipation Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Idiopathic Constipation Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Idiopathic Constipation Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2022-2027)
Figure 14. Global Chronic Idiopathic Constipation Drugs Market Share by Players in 2020
Figure 15. Global Top Chronic Idiopathic Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Drugs Revenue in 2020
Figure 17. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Idiopathic Constipation Drugs Market Share by Type (2016-2027)
Figure 21. North America Chronic Idiopathic Constipation Drugs Market Share by Application (2016-2027)
Figure 22. North America Chronic Idiopathic Constipation Drugs Market Share by Country (2016-2027)
Figure 23. United States Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Idiopathic Constipation Drugs Market Share by Type (2016-2027)
Figure 27. Europe Chronic Idiopathic Constipation Drugs Market Share by Application (2016-2027)
Figure 28. Europe Chronic Idiopathic Constipation Drugs Market Share by Country (2016-2027)
Figure 29. Germany Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Share by Region (2016-2027)
Figure 39. China Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Idiopathic Constipation Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Idiopathic Constipation Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Idiopathic Constipation Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 59. Glaxosmithkline Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 60. Roche Holding AG Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 62. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 65. Allergens Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 66. Chugai Pharmaceutical Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 67. Ferring International Center S.A Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 68. Synergy Pharmaceuticals Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 69. Salix Pharmaceuticals Ltd Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 70. Sucampo Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 71. Ironwood Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 72. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 73. Daiichi Sankyo Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 74. Cosmo Pharmaceuticals SA Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 75. Progenics Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 76. Theravance Biopharma Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の慢性特発性骨髄線維症市場規模・現状・予測（2021年-2027年） Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…- 世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の便秘市場規模・現状・予測（2021年-2027年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …
- 世界の便秘市場規模・現状・予測（2021年-2027年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …